+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The clinical evaluation of a new long-acting anticholinergic drug



The clinical evaluation of a new long-acting anticholinergic drug



American Journal of Gastroenterology 34: 179-182




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 050586914

Download citation: RISBibTeXText

PMID: 14400468


Related references

Clinical evaluation of three long-acting anticholinergic compounds. Gut 9(5): 590-596, 1968

Hexocyclium methosulfate in active duodenal ulcer; evaluation of a new anticholinergic drug in conventional and long-acting forms, especially its effect on gastric pH as studied in 48-hour analysis. American Journal of Digestive Diseases 3(1): 12-23, 1958

Tiotropium: An inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease. Pharmacotherapy 23(2): 183-189, 2003

Clinical experience with a new long-acting ant-acid-anticholinergic preparation. American Journal of Gastroenterology 32: 509-517, 1959

Hexocyclium Methosulfate, a New Anticholinergic Drug in Conventional and Long-Acting Forms: Its Effects on Gastric Secretion. Pathobiology 21(2): 354-362, 1958

Clinical and experimental observations in peptic ulcer with a new, prolonged-acting anticholinergic drug. American Journal of Gastroenterology 29(6): 585-92; Discussion 592-5, 1958

A preliminary evaluation of a new long-acting anticholinergic in peptic ulcer and other digestive diseases. American Journal of Gastroenterology 28(4): 446-451, 1957

Compare the efficacy and safety of long-acting anticholinergic and a combination of inhaled steroids and long-acting beta-2 agonist in moderate chronic obstructive pulmonary disease. Tuberkuloz Ve Toraks 64(2): 112-118, 2017

Treatment of respiratory disease in beef cattle. Comparison of the clinical efficacy of a long-acting drug with that of non-long-acting agents. Obiettivi e Documenti Veterinari 20(3): 55-59, 1999

Long-acting tranquilizer-anticholinergic in gastrointestinal disorders: an experimental and clinical study. American Journal of Gastroenterology 33: 73-79, 1960

An evaluation of a long-acting anticholinergic-antacid in the treatment of peptic ulcer and other diseases of the digestive tract. American Journal of Gastroenterology 37: 73-78, 1962

Clinical evaluation of methyclothiazide, a new potent long-acting oral diuretic drug. Henry Ford Hospital Medical Bulletin 9: 440-449, 1961

Pharmacological and clinical profile of tiotropium bromide (Spiriva), a new long-acting anticholinergic bronchodilator for COPD treatment. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 125(5): 307-313, 2005

A Long Acting Anticholinergic-Sedative Combination in Gastrointestinal Disorders. Clinical Trial of Oxyphencyclimine Hydrochloride with Phenobarbital (Daricon Pb). Journal of the National Medical Association 56: 244-247, 1964

Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial. JAMA 314(16): 1720-1730, 2015